Alcohol may ease the nerves that cause atrial fibrillation

March 4, 2014 by David Bricker
Doctors found a few small injections of ethanol appeared to damage the nerve clusters that cause atrial fibrillation.

(Medical Xpress)—Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.

Principal investigator Miguel Valderrábano, M.D., chief of at Houston Methodist DeBakey Heart & Vascular Center, found that adding four or fewer injections of 98 percent ethanol to the catheter-aided radio wave ablation of nerve clusters near the vein of Marshall was enough to damage or kill the nerves. Doing so prevented the doctors from being able to artificially trigger atrial fibrillation using electricity. Electrical stimulation is used during atrial fibrillation procedures to determine whether ablations were successful.

"This is a therapy that targets cardiac nerves previously shown to be involved in atrial fibrillation," Valderrábano said. "Radiofrequency ablation carries risks of collateral damage to other structures and there are also risks associated with surgical approaches. We show that chemical ablation with can achieve elimination of abnormal nerve activity, introducing a catheter through a neck vein and doing all the work through it."

The addition of alcohol appeared to be far more effective at disrupting the nerves than the standard surgical therapy alone—concentrated radio waves that cause tissues in a small area to burn and scar.

"The present study shows the addition of ethanol to the vein of Marshall could improve the effectiveness of standard therapies," Valderrábano said. "Next, we need to look at short and long term outcomes so we can know which therapy works better for patients."

Catheter ablation is an effective treatment for atrial fibrillation, or a-fib, but the fix is not always permanent. Many patients find their a-fib returns months or years after the first procedure, and many opt to undergo a second ablation operation. Valderrábano and others are investigating how procedures might be improved so they only need to be done once.

High frequency electrical stimulation was used to test the activity of nerve clusters and to verify that nerve activity could induce atrial fibrillation. Before treatment, stimulation induced a-fib in all patients. After alcohol injection in the vein of Marshall, never induced atrial fibrillation.

The researchers examined blood alcohol concentration for those patients who received alcohol treatment, and found they could detect no alcohol. The highest dose was 4 milliliters (four 1-milliliter injections of 98 percent ethanol), and the average body contains more than 1,000 times that volume in blood. By comparison, a can of American beer contains 10-15 milliliters of ethanol.

The researchers also said there appeared to be no complications related to alcohol infusion or access to the vein of Marshall nerve cluster.

Cardiac arrhythmia is a general condition in which the heart does not beat correctly, and is the most common type. In a-fib, one or both of the heart's upper two chambers quiver in between beats. This disrupts blood flow and weakens the power with which the heart pumps oxygenated blood to all parts of the body. A rapid heart rate is a typical symptom. Other possible symptoms are heart palpitations, an inability to do sustained physical activity, chest pains, and edema. A-fib is uncommon in younger adults, but its prevalence increases with age. One in twelve people over 80 have a-fib. The average age of study volunteers in the JACC report was about 64.

Explore further: High frequency source ablation effective in treating atrial fibrillation

More information: José L. Báez-Escudero, Takehiko Keida, Amish S. Dave, Kaoru Okishige, Miguel Valderrábano, "Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: Implications for atrial fibrillation," Journal of the American College of Cardiology, Available online 19 February 2014, ISSN 0735-1097, dx.doi.org/10.1016/j.jacc.2014.01.032.

Related Stories

High frequency source ablation effective in treating atrial fibrillation

November 20, 2013
High frequency source ablation is as safe and effective as a more standard ablation treatment for patients with paroxysmal atrial fibrillation, according to a late-breaking clinical trial presented at the American Heart Association's ...

Beaumont Health System first outside of Japan to test new atrial fibrillation technology

January 31, 2014
Beaumont Health System is the first center outside of Japan to use a new balloon ablation technology to treat atrial fibrillation, the most common heart rhythm disorder that affects about 3 million people in the U.S.

Study supports 3-D MRI heart imaging to improve treatment of atrial fibrillation

February 5, 2014
A University of Utah-led study for treatment of patients with atrial fibrillation (A-fib) provides strong clinical evidence for the use of 3-D MRI to individualize disease management and improve outcomes.

MRIs help predict which atrial fibrillation patients will benefit from catheter ablation

February 4, 2014
A new type of contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from a treatment called catheter ablation, according to a landmark multi-center study published in the Journal ...

Study examines use of electrical energy for treating certain type of atrial fibrillation

February 18, 2014
Among patients with untreated paroxysmal (intermittent) atrial fibrillation (AF), treatment with electrical energy (radiofrequency ablation) resulted in a lower rate of abnormal atrial rhythms and episodes of AF, according ...

Specific heart contractions could predict atrial fibrillation

December 2, 2013
A commonly used heart monitor may be a simple tool for predicting the risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UC San Francisco.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.